Testing a new cell injection for advanced blood cancers

This trial is testing a new treatment called GT719 Universal Cell Injection for adults with certain blood cancers (B-cell lymphoma or B-cell acute lymphoblastic leukemia) that have come back or stopped responding to previous treatments. The medication is a specially prepared cell injection designed to fight these hard-to-treat cancers. Researchers want to learn whether the treatment is safe and whether it works to help patients.

When blood cancers come back or no longer respond to standard treatments, patients have very few options left. This medication represents a new approach—using immune cells to attack these cancers—and this trial is the first step to see if it could offer hope to patients who have run out of other choices.